Clinical trial · Observational
Chronic Intestinal Pathologies Analytical Cohort at TouLouse
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In the general population, the percentage of people with at least one digestive disease is 16.7%. Among these digestive diseases, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and patients who should benefit from digestive examinations as part of a screening oriented either by the patient's family history or following the performance of an immunological screening test ( FIT) in the stool will be studied. The aim of this project is to build a biological collection with associated clinical data for research projects.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Inflammatory Bowel Diseases | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| blood and intestinal biopsy sampling | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patient screened or followed-up for IBS or IBD or colorectal cancer
- description
- Blood and colon biopsy sampling
- interventionNames
- Biological: blood and intestinal biopsy sampling
Primary outcomes (2)
- measure
- Biological collection associated with clinical data
- timeFrame
- Baseline
- description
- Set up a biological collection associated with clinical data on main intestinal tract diseases in order to understand their physiopathology
- measure
- Biological collection associated with clinical data
- timeFrame
- pre-intervention/procedure/surgery
- description
- Set up a biological collection associated with clinical data on main intestinal tract diseases in order to understand their physiopathology
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * Patient requiring endoscopic explorations for screening or follow-up in the context of a suspected IBS or IBD or colorectal cancer Or * Patient with IBD requiring surgical management * Patient over 18 years old * Patient able to read and understand the information leaflet * Patients who have given their consent to participate in the study * Patients affiliated to a social security system (including AME) Exclusion Criteria: * Patients who have received antibiotic treatments in the 10 days preceding endoscopic exploration * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curatorship * Patients unable to sign a free and informed consent
References
Publications (0)
Data not yet available